专利号:US-8921312-B2 优先权日:2006-06-05 标题 :Combination of insulin and ascorbate to enhance wound healing 发明人:MUSSELMANN KURT; HASSELL JOHN R; KANE BRAD; ALEXANDROU BRIDGETTE 权利人:MUSSELMANN KURT; HASSELL JOHN R; KANE BRAD; ALEXANDROU BRIDGETTE; UNIV SOUTH FLORIDA 摘要:Provided is a method of stimulating collagen synthesis and proteoglycan (lumican and keratocan) accumulation. Collagenase isolated keratocytes were cultured with or without insulin with or without ascorbate. Insulin stimulates the synthesis of collagen but does not affect the accumulation of lumican and keratocan. Insulin plus ascorbate, however, stimulates the synthesis of collagen and increased the accumulation of these proteoglycans. The accumulation of PGDS, a KSPG that does not interact with collagen, is not affected by ascorbate. Only the collagen made in the presence of ascorbate was pepsin resistant. EDB overrode the effects of ascorbate on pepsin resistance and proteoglycan accumulation.
专利号:WO-2007145934-A1 优先权日:2006-06-05 标题 :Combination of insulin and ascorbate to enhance wound healing 发明人:MUSSELMANN KURT; HASSELL JOHN R; KANE BRAD; ALEXANDROU BRIDGETTE 权利人:UNIV SOUTH FLORIDA; MUSSELMANN KURT; HASSELL JOHN R; KANE BRAD; ALEXANDROU BRIDGETTE 摘要:Provided is a method of stimulating collagen synthesis and proteoglycan (lumican and keratocan) accumulation. Collagenase isolated keratocytes were cultured with or without insulin with or without ascorbate. Insulin stimulates the synthesis of collagen but does not affect the accumulation of lumican and keratocan. Insulin plus ascorbate, however, stimulates the synthesis of collagen and increased the accumulation of these proteoglycans. The accumulation of PGDS, a KSPG that does not interact with collagen, is not affected by ascorbate. Only the collagen made in the presence of ascorbate was pepsin resistant. EDB overrode the effects of ascorbate on pepsin resistance and proteoglycan accumulation.
专利号:US-9359370-B2 优先权日:2008-07-08 标题 :Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof 发明人:WANG YINXIANG; XIE GUOJIAN; DING LIEMING; TAN FENLAI; HU YUNYAN; HE WEI; HAN BIN; LONG WEI; LIU YONG; Ai haima; DAVIS CHARLES; ZHANG DON 权利人:BETA PHARMA INC 摘要:The invention relates to 4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crown-quinazoline hydrochloride, its new crystalline forms, its therapeutic usage for treatment of diseases mediated by EGFR kinase and its combinatory therapeutic usage together with other therapeutic agents. The invention also provides synthetic methods for preparation of 4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crown-quinazoline hydrochloride, its new crystalline forms, and the relevant synthetic intermediates for synthesis of 4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crown-quinazoline hydrochloride.
专利号:US-8133999-B2 优先权日:2003-07-30 标题 :Process for preparation of 6, 7-bis(2-methoxyethoxy) quinazolin-4-one 发明人:NISHINO SHIGEYOSHI; HIROTSU KENJI; SHIMA HIDETAKA; ODA HIROYUKI; SUZUKI SHINOBU 权利人:NISHINO SHIGEYOSHI; HIROTSU KENJI; SHIMA HIDETAKA; ODA HIROYUKI; SUZUKI SHINOBU; UBE INDUSTRIES 摘要:6,7-Bis(2-methoxyethoxy)quinazolin-4-one of formula (5) useful in synthesis of an anti-cancer drug can be prepared by a reaction of ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate of formula (4) with an orthoformic acid in the presence of an ammonium acetate:
专利号:US-11162129-B2 优先权日:2016-11-09 标 题 :Photoprotective mixtures as imaging reagents in sequencing-by-synthesis 发明人:ANDRUZZI LUISA; Perbost Michel Georges; HEVRONI DONA; GUHA MINAKSHI; RICKER AUSTIN; PELLETIER TIMOTHY 权利人:ISOPLEXIS CORP 摘要:The invention relates to methods, compositions, devices, systems and kits as described including, without limitation, reagents and mixtures for determining the identity of nucleic acids in nucleotide sequences using, for example, sequencing by synthesis methods. In particular, the present invention contemplates the use of photoprotective mixture of compounds as imaging reagents to improve stability and storage of fluorescent compounds, including but not limited to, nucleotides with fluorescent labels.
专利号:US-2023293530-A1 优先权日:2020-06-24 标 题:Agents for sensitizing solid tumors to treatment 发明人:EREZ AYELET; KESHET ROM; ADLER LITAL; RUPPIN EYTAN; SANG LEE JOO 权利人:YEDA RES & DEV; THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC 摘要:An agent which increases pyrimidine to purine ration in a cell without decreasing pyrimidine synthesis for use in a method of treating a solid tumor in a subject in need thereof, optionally in combination with an immune-modulating drug.
1: Harnoss JM, Platzer LK, Burhenne J, Radhakrishnan P, Cai J, Strowitzki MJ, Weiss J, Ritter AS, Mollenhauer M, Schmidt T, Ulrich A, Haefeli WE, Schneider M. Prolyl Hydroxylase Inhibition Enhances Liver Regeneration Without Induction of Tumor Growth. Ann Surg. 2017 Apr;265(4):782-791. doi: 10.1097/SLA.0000000000001696. eCollection 2016. 3: Pizzute T, Zhang Y, He F, Pei M. Ascorbate-dependent impact on cell-derived matrix in modulation of stiffness and rejuvenation of infrapatellar fat derived stem cells toward chondrogenesis. Biomed Mater. 2016 Aug 10;11(4):045009. doi: 10.1088/1748-6041/11/4/045009. 4: Huang M, Paglialunga S, Wong JM, Hoang M, Pillai R, Joseph JW. Role of prolyl hydroxylase domain proteins in the regulation of insulin secretion. Physiol Rep. 2016 Mar;4(5). pii: e12722. doi: 10.14814/phy2.12722.
合成参考文献
摘要:Nguyen, B. N.; Hii, K. K.; Szymański, W.; Janssen, D. B., Science of Synthesis: Stereoselective Synthesis, (2011) 1, 612. 摘要:Inamoto, K., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 2, 417. 摘要:Li, D.-D.; Wang, G.-W., Science of Synthesis: Catalytic Transformations via CH Activation, (2015) 2, 355. 摘要:H. Harada, Nippon Kagaku Zasshi 90, 267 (1969); CA 71, 12391g. 参考文献:10.1007/bf02343075 摘要:Saika S, Ooshima A, Yamanaka O, Okada Y, Tanaka S, Ohnishi Y. Effect of fibrostatin C, an inhibitor of prolyl 4-hydroxylase, on collagen secretion by human Tenon's capsule fibroblasts in vitro. Graefe's Archive for Clinical and Experimental Ophthalmology. 1996 Aug;234(Suppl 1):s214–22. doi: 10.1007/bf02343075.